We are live on ! Find out more
ESPR

Esperion Therapeutics
ESPR

Delisted

ESPR was delisted on the 10th of July, 2026.

119 hedge funds and large institutions have $647M invested in Esperion Therapeutics in 2017 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 38 increasing their positions, 31 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more funds holding in top 10

Funds holding in top 10: 15 (+4)

248% more capital invested

Capital invested by funds: $186M → $647M (+$461M)

236% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 11

23% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 31

20% more funds holding

Funds holding: 99119 (+20)

15.49% more ownership

Funds ownership: 65.72%81.22% (+15%)

70% less call options, than puts

Call options by funds: $19.7M | Put options by funds: $66.3M

Holders
119
Holders Change
+20
Holders Change %
+20.2%
% of All Funds
2.96%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.12%
New
37
Increased
38
Reduced
31
Closed
11
Calls
$19.7M
Puts
$66.3M
Net Calls
-$46.6M
Net Calls Change
-$48.9M
Name Holding Trade Value Shares
Change
Change in
Stake
USAA
126
United Services Automobile Association
Texas
-$442K -35,280 Closed
D.E. Shaw & Co
127
D.E. Shaw & Co
New York
-$310K -24,796 Closed
VRS
128
Virginia Retirement Systems
Virginia
-$283K -22,600 Closed
TRCT
129
Tower Research Capital (TRC)
New York
-$34.8K -1,518 -100%
AG
130
Advisor Group
Arizona
-$3K -200 Closed